NASDAQ:MDSO - Medidata Solutions Stock Price, News & Analysis

Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."

Medidata Solutions Inc (NASDAQ:MDSO) posted its quarterly earnings results on Monday, July, 22nd. The company reported $0.48 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.31. The firm had revenue of $180.50 million for the quarter, compared to analysts' expectations of $179.95 million. Medidata Solutions had a return on equity of 8.64% and a net margin of 6.43%. The company's revenue for the quarter was up 15.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.43 EPS. View Medidata Solutions' Earnings History.

Medidata Solutions is scheduled to release their next quarterly earnings announcement on Thursday, October 17th 2019. View Earnings Estimates for Medidata Solutions.

9 equities research analysts have issued twelve-month target prices for Medidata Solutions' shares. Their predictions range from $70.00 to $96.00. On average, they anticipate Medidata Solutions' share price to reach $84.4288 in the next twelve months. This suggests that the stock has a possible downside of 7.8%. View Analyst Price Targets for Medidata Solutions.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 8 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Medidata Solutions.

Press coverage about MDSO stock has been trending positive on Thursday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Medidata Solutions earned a media sentiment score of 2.5 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the stock's share price in the immediate future. View News Stories for Medidata Solutions.

Some companies that are related to Medidata Solutions include Crowdstrike (CRWD), Cadence Design Systems (CDNS), Synopsys (SNPS), Splunk (SPLK), CA (CA), ANSYS (ANSS), Twilio (TWLO), Check Point Software Technologies (CHKP), Atlassian (TEAM), TAKE-TWO INTERACTIVE SOFTWARE (TTWO), Symantec (SYMC), Paycom Software (PAYC), Tableau Software (DATA), Okta (OKTA) and Citrix Systems (CTXS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA), Applied Materials (AMAT), salesforce.com (CRM), Gilead Sciences (GILD), Allergan (AGN), GrubHub (GRUB), IBM (IBM), Celgene (CELG), Alphabet (GOOG) and Intel (INTC).

Medidata Solutions' stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.99%), Vanguard Group Inc. (8.75%), Brown Capital Management LLC (6.30%), Janus Henderson Group PLC (2.48%), Janus Henderson Group PLC (2.48%) and Alpine Associates Management Inc. (2.31%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Daniel Patrick Shannon, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Institutional Ownership Trends for Medidata Solutions.

MDSO stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., ARK Investment Management LLC, Eagle Asset Management Inc., Bank of New York Mellon Corp, Global Thematic Partners LLC, Pictet Asset Management Ltd., Peregrine Capital Management LLC and Janus Henderson Group PLC. Company insiders that have sold Medidata Solutions company stock in the last year include Daniel Patrick Shannon, Michael I Otner, Michael Pray, Robert Taylor and Rouven Bergmann. View Insider Buying and Selling for Medidata Solutions.

MDSO stock was bought by a variety of institutional investors in the last quarter, including Alpine Associates Management Inc., Magnetar Financial LLC, Echo Street Capital Management LLC, ARP Americas LP, Morgan Stanley, Syquant Capital Sas, Pentwater Capital Management LP and Water Island Capital LLC. View Insider Buying and Selling for Medidata Solutions.

Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MDSO stock can currently be purchased for approximately $91.61.

Medidata Solutions has a market capitalization of $5.72 billion and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis. Medidata Solutions employs 1,998 workers across the globe.View Additional Information About Medidata Solutions.

The official website for Medidata Solutions is http://www.mdsol.com/.

Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]